IMMUNIC, INC. Earnings Per Share Diluted

Quick Answer

IMMUNIC, INC. reported Earnings Per Share Diluted of $0.62 (loss) per share for the year ending 2025.

  • IMMUNIC, INC. showed an increase of +38.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), IMMUNIC, INC.'s Earnings Per Share Diluted has grown by 77.9%.
  • Historical annual values: Fiscal year 2025: $0.62 (loss) per share | Fiscal year 2024: $1.00 (loss) per share | Fiscal year 2023: $2.11 (loss) per share | Fiscal year 2022: $3.78 (loss) per share | Fiscal year 2021: $3.93 (loss) per share | Fiscal year 2020: $2.81 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: